PCVX financial statements and SEC filings
PCVX annual income statement
| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
|---|
| 2025-12-31 | – | -$923.67M | -$766.63M | 10-K |
| 2024-12-31 | – | -$569.55M | -$463.93M | 10-K |
| 2023-12-31 | – | -$468.04M | -$402.27M | 10-K |
| 2022-12-31 | – | -$232.26M | -$223.49M | 10-K |
| 2021-12-31 | – | -$103.67M | -$100.08M | 10-K |
| 2020-12-31 | – | -$89.58M | -$89.22M | 10-K |
PCVX annual balance sheet
| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
|---|
| 2025-12-31 | $3.00B | $317.21M | $2.69B | 10-Q |
| 2024-12-31 | $3.51B | $205.50M | $3.31B | 10-K |
| 2023-12-31 | $1.41B | $167.45M | $1.24B | 10-K |
| 2022-12-31 | $1.01B | $52.56M | $953.61M | 10-K |
| 2021-12-31 | $324.34M | $40.32M | $284.02M | 10-K |
| 2020-12-31 | $392.83M | $46.98M | $345.84M | 10-K |
PCVX annual cash flow
| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
|---|
| 2025-12-31 | -$655.58M | -$13.71M | $2.01M | 10-K |
| 2024-12-31 | -$452.63M | -$22.43M | $2.45B | 10-K |
| 2023-12-31 | -$296.79M | -$16.06M | $639.81M | 10-K |
| 2022-12-31 | -$170.60M | -$5.84M | $861.55M | 10-K |
| 2021-12-31 | -$121.39M | -$6.55M | $17.80M | 10-K |
| 2020-12-31 | -$46.63M | -$1.16M | $374.87M | 10-K |